We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEIS icon
1026
Advanced Energy
AEIS
$13.2B
$42.1M ﹤0.01%
489,273
-5,317
-1% -$460K
CHD icon
1027
Church & Dwight Co
CHD
$24B
$42.1M ﹤0.01%
423,460
-32,095
-7% -$3.2M
EXP icon
1028
Eagle Materials
EXP
$6.41B
$41.9M ﹤0.01%
326,493
-111,371
-25% -$15.8M
IMGO
1029
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$41.9M ﹤0.01%
2,172,235
-69,682
-3% -$1.45M
ALK icon
1030
Alaska Air
ALK
$5.3B
$41.6M ﹤0.01%
716,963
+55,636
+8% +$3.03M
WIX icon
1031
WIX.com
WIX
$3.35B
$41.5M ﹤0.01%
397,757
-38,886
-9% -$4.24M
BF.B icon
1032
Brown-Forman Class B
BF.B
$12.9B
$41.2M ﹤0.01%
615,189
-61,928
-9% -$4.12M
WWD icon
1033
Woodward
WWD
$21.2B
$41.2M ﹤0.01%
329,831
-57,291
-15% -$6.74M
DICE
1034
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$41M ﹤0.01%
2,143,684
+390,893
+22% +$6.98M
AIN icon
1035
Albany International
AIN
$1.82B
$40.9M ﹤0.01%
484,990
-14,847
-3% -$1.28M
PDCE
1036
DELISTED
PDC Energy, Inc.
PDCE
$40.6M ﹤0.01%
558,653
+8,449
+2% +$523K
IRDM icon
1037
Iridium Communications
IRDM
$5.27B
$40.6M ﹤0.01%
1,006,115
+101,760
+11% +$3.83M
HGV icon
1038
Hilton Grand Vacations
HGV
$3.49B
$40.4M ﹤0.01%
777,683
+12,983
+2% +$655K
LEN icon
1039
Lennar Class A
LEN
$21.1B
$40.3M ﹤0.01%
512,827
+21,209
+4% +$1.91M
JJSF icon
1040
J&J Snack Foods
JJSF
$1.7B
$40.2M ﹤0.01%
259,220
-10,645
-4% -$1.65M
PFHD
1041
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$40.2M ﹤0.01%
1,781,280
-9,494
-0.5% -$202K
SUI icon
1042
Sun Communities
SUI
$14.6B
$40.1M ﹤0.01%
228,790
+12,488
+6% +$2.32M
CERN
1043
DELISTED
Cerner Corp
CERN
$40.1M ﹤0.01%
428,117
-13,359
-3% -$1.24M
CAE icon
1044
CAE Inc. Common Shares
CAE
$8.47B
$39.9M ﹤0.01%
1,532,996
+8,463
+0.6% +$215K
CNMD icon
1045
CONMED
CNMD
$1.49B
$39.9M ﹤0.01%
268,361
+1,419
+0.5% +$198K
RRGB icon
1046
Red Robin
RRGB
$183M
$39.7M ﹤0.01%
2,356,468
+51,805
+2% +$837K
RCKT icon
1047
Rocket Pharmaceuticals
RCKT
$367M
$39.7M ﹤0.01%
2,502,386
+309,492
+14% +$5.35M
BIO icon
1048
Bio-Rad Laboratories Class A
BIO
$9.66B
$39.6M ﹤0.01%
70,384
-3,073
-4% -$1.85M
APEI icon
1049
American Public Education
APEI
$828M
$39.2M ﹤0.01%
1,845,039
+400
+0% +$8.43K
KMX icon
1050
CarMax
KMX
$8.52B
$39.1M ﹤0.01%
404,889
-244,591
-38% -$26.3M

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.